Weight loss enhances cardiac energy metabolism and function in heart failure associated with obesity. Issue 8 (4th June 2019)

• Record Type: Journal Article
• Authors: Karwi, Qutuba G.; Zhang, Liyan; Altamimi, Tariq R.; Wagg, Cory S.; Patel, Vaibhav; Uddin, Golam M.; Joerg, Alice R.; Padwal, Raj S.; Johnstone, David E.; Sharma, Arya; Oudit, Gavin Y.; Lopaschuk, Gary D.
• Is Part Of: Diabetes, obesity & metabolism. Volume 21:Issue 8(2019)
• Page Start: 1944
• Page End: 1955
• Publication Date: 2019-06-04
• Subjects: acetylation -- fatty acid oxidation -- glucose oxidation -- heart failure -- obesity -- weight loss; Diabetes -- Periodicals; Obesity -- Periodicals; Metabolism -- Disorders -- Periodicals; Clinical pharmacology -- Periodicals; 616.462
• DOI: 10.1111/dom.13762
• Languages: English
• ISSNs: 1462-8902

Abstract

Abstract: Aims: Obesity is associated with high rates of cardiac fatty acid oxidation, low rates of glucose oxidation, cardiac hypertrophy and heart failure. Whether weight loss can lessen the severity of heart failure associated with obesity is not known. We therefore determined the effect of weight loss on cardiac energy metabolism and the severity of heart failure in obese mice with heart failure. Materials and methods: Obesity and heart failure were induced by feeding mice a high‐fat (HF) diet and subjecting them to transverse aortic constriction (TAC). Obese mice with heart failure were then switched for 8 weeks to either a low‐fat (LF) diet (HF TAC LF) or caloric restriction (CR) (40% caloric intake reduction, HF TAC CR) to induce weight loss. Results: Weight loss improved cardiac function (%EF was 38 ± 6% and 36 ± 6% in HF TAC LF and HF TAC CR mice vs 25 ± 3% in HF TAC mice, P < 0.05) and it decreased cardiac hypertrophy post TAC (left ventricle mass was 168 ± 7 and 171 ± 10 mg in HF TAC LF and HF TAC CR mice, respectively, vs 210 ± 8 mg in HF TAC mice, P < 0.05). Weight loss enhanced cardiac insulin signalling, insulin‐stimulated glucose oxidation rates (1.5 ± 0.1 and 1.5 ± 0.1 μmol/g dry wt/min in HF TAC LF and HF TAC CR mice, respectively, vs 0.2 ± 0.1 μmol/g dry wt/min in HF TAC mice, P < 0.05) and it decreased pyruvate dehydrogenase phosphorylation. Cardiac fatty acid oxidation rates, AMPK Tyr172 /ACC Ser79 signalling and the acetylation of ß‐oxidation enzymes, were attenuated following weight loss. Conclusions: Weight loss is an effective intervention to improve cardiac function and energy metabolism in heart failure associated with obesity.